Primary Aldosteronism: Superselective Embolization vs. Laparoscopic Endocrine Curative Therapy

Clinical trial NCT06513585 · RECRUITING

Trial details

NCT number: NCT06513585
Sponsor: Xinjiang Medical University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Primary Aldosteronism Suprarenalectomy Super Selective Adrenal Artery Embolization

Start date: 2024-08-01
Primary completion: 2026-05-01
Enrollment: 570

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.